Page last updated: 2024-10-27

fluorouracil and Abnormalities, Digestive System

fluorouracil has been researched along with Abnormalities, Digestive System in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Sanna'a, NA1
Van Kuilenburg, AB1
Atrak, TM1
Abdul-Jabbar, MA1
Van Gennip, AH1
Stephens, JD1
Golbus, MS1
Miller, TR1
Wilber, RR1
Epstein, CJ1

Other Studies

2 other studies available for fluorouracil and Abnormalities, Digestive System

ArticleYear
Dihydropyrimidine dehydrogenase deficiency presenting at birth.
    Journal of inherited metabolic disease, 2005, Volume: 28, Issue:5

    Topics: Age of Onset; Antimetabolites; Binding Sites; Digestive System Abnormalities; Dihydropyrimidine Dehy

2005
Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester.
    American journal of obstetrics and gynecology, 1980, Jul-15, Volume: 137, Issue:6

    Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Bone and Bones; Digestive System Abnorm

1980